About Bruce Krattenmaker
Form D filings for Alucent Biomedical in 2023 list Bruce Krattenmaker as executive officer.
Bruce Krattenmaker first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Bruce Krattenmaker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bruce Krattenmaker works with at each company, as listed on that company's latest Form D.
Alucent Biomedical, Inc. · Form D, Apr 20, 2023
JL
Julie Lautt
Director
JC
James Corbett
Director
KW
Kevin Warner
Executive officer
CJ
Colin Jackson
Executive officer
MG
Myles Greenberg
President and director
DF
David Flicek
Director
KK
Katalin Kauser
Executive officer
DP
Daniel Pelak
Director
NP
Nick Pappas
Director
JI
James Isaacson
Executive officer
HH
Henry Hauser
Executive officer